+3 year(s) experience
David Writes For
By David Ridley 18 Dec 2019
Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."
By David Ridley 13 Nov 2019
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
By David Ridley 07 Aug 2019
Japan's new Rx-to-OTC switch procedure has exacerbated a "switch lag" compared with developed countries, says Japan Self-Medication Industry senior adviser Toshi Tominaga in an exclusive interview with HBW Insight. Tominaga proposes improvements such as self-care education for consumers and drug usage advice included by firms in switch applications to help balance the risk-benefit decisions of expert judges.
Topic Policy and regulation
By David Ridley 05 Jul 2019
The UK's cannabidiol market, which according to the Cannabis Trades Association is the largest in Europe, awaits clarification on the legal status of CBD-containing food supplements. Meanwhile, major retailers like Walgreen Boots Alliance are stepping into the space with branded products.
By David Ridley 07 Mar 2019
A new position paper by Food Supplements Europe calculates the potential savings that targeted supplementation with omega-3, calcium, phytosterols and vitamins D and B9 could bring for cash-strapped European governments.
18 Oct 2019